Ai, Shaolong
Xiang, Xiao-Na https://orcid.org/0000-0001-8659-1080
Yu, Xi
Liu, Yan
Zhang, Kaibo
Zhang, Xuyang
Jiang, Hongying
Wang, Qian
He, Hong-Chen https://orcid.org/0000-0002-3016-022X
Funding for this research was provided by:
National Natural Science Foundation of China (82302884)
Science & Technology Department of Sichuan Province (2022NSFSC1312)
Article History
Received: 25 July 2024
Accepted: 11 June 2025
First Online: 4 July 2025
Change Date: 14 July 2025
Change Type: Update
Change Details: The original version of this article was revised: in the captions of Tables 2 and 3, the question mark (?) within the section [M (Q1?Q3)] should be replaced with a comma (,).
Declarations
:
: This study was approved by the Biomedical Research Ethics Committee of West China Hospital of Sichuan University No. 2023 (633) and Clinical Trial Registration No. ChiCTR2300074199 registered in 2023.8.1. The study adheres to the ethical guidelines set forth by the Declaration of Helsinki. Each participant was provided with comprehensive information about the study’s purpose, procedures, and potential risks. They were given the opportunity to ask questions and ensure they understood the study before consenting to participate.
: Written patient consent was obtained for publication of all aspects of the case including personal and clinical details and images, which may compromise anonymity.
: The authors declare no competing interests.